PA
BTDR icon

PharVision Advisers’s Bitdeer Technologies BTDR Stock Holding History

PharVision Advisers’s Portfolio BTDR Stock Details BTDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,951
Closed -$112K – 75
2026
Q1 		$112K Buy
+12,951
New +$136K 1.14% 39

Other funds holding BTDR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return
CCM
Clearfield Capital Management New York $143M AUM 158.48% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

PharVision Advisers's BTDR Position: Q2 2026 in Review

PharVision Advisers sold out of Bitdeer Technologies (BTDR) in Q2 2026, closing a stake of 12,951 shares — an estimated $112K sold.

PharVision Advisers first reported a position in BTDR in Q1 2026 and held it in 1 quarter. The position peaked at $112K in Q1 2026. 237 funds tracked by Wall St. Rank hold BTDR as of Q2 2026.

  • PharVision Advisers reported no remaining Bitdeer Technologies position as of Q2 2026 after selling out during the quarter.
  • PharVision Advisers sold 12,951 Bitdeer Technologies shares in Q2 2026, an estimated $112K.
  • PharVision Advisers first reported a position in Bitdeer Technologies in Q1 2026 and held it in 1 quarter.
  • PharVision Advisers's Bitdeer Technologies position peaked at $112K in Q1 2026.
  • 237 funds tracked by Wall St. Rank held Bitdeer Technologies as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.